Medline (MDLN) risk factors, FY2025 10-K

Risks Related to Our Business, Industry, and Operations

1. 01Our global operations are subject to inherent risks that could materially adversely affect our business, results of operations, and financial condition
2. 02We may be unable to derive fully the anticipated benefits from our existing or future acquisitions, joint ventures, investments, dispositions, or other strategic transactions
3. 03Consolidation in the healthcare industry could have an adverse effect on our business, results of operations, and financial condition
4. 04We operate in a highly competitive industry, with accelerating pricing pressure and changes in technology
5. 05Changes to the U.S. and global healthcare environments may not be favorable to us
6. 06Increases in shipping costs or service issues with our third-party shippers could harm our business
7. 07Significant challenges or delays in our sourcing of new products and technologies could have an adverse impact on our long-term success
8. 08We have concentration in and dependence on certain healthcare provider customers and GPOs
9. 09We may be unable to attract, develop, and retain key employees
10. 10Our business and operations depend on the proper functioning of our critical facilities and distribution networks and could be negatively impacted by events outside our control
11. 11We may be required to recognize impairment charges related to goodwill, identified intangible assets, and fixed assets that would reduce our reported assets and earnings
12. 12We may not realize the expected benefits from the entry into new or amended contracts, planned cost savings, and business improvement initiatives
13. 13Quality problems and product liability claims have in the past led, and could in the future lead, to recalls or safety alerts, reputational harm, adverse verdicts, or costly settlements, and could have a material adverse effect on our business, results of operations, and financial condition
14. 14Our failure to establish and maintain Prime Vendor relationships may cause our revenue to decline
15. 15If we experience increased pressure to maintain or decrease the price of our goods and services and we are unable to reduce our expenses, there may be a material adverse effect on our business, results of operations, and financial condition
16. 16Any failure by or loss of a third-party manufacturer or supplier or other manufacturing or supply-related impacts could result in delays and increased costs, which may adversely affect our business

Risks Related to Regulation and Legal Proceedings

1. 17We rely on the proper function, security, and availability of our information technology systems and data, as well as those of third parties throughout our global supply chain, to operate our business
2. 18We are subject to extensive and complex laws and governmental regulations and any adverse regulatory action may materially adversely affect our business, results of operations, and financial condition both inside and outside the United States
3. 19We are subject to extensive environmental, health, and safety requirements, and our operations involve hazardous and other environmentally sensitive substances
4. 20The failure to comply with anti-corruption laws or trade restrictions, including economic sanctions, could materially adversely affect our business, results of operations, and financial condition and result in civil and/or criminal penalties
5. 21We are subject to complex and rapidly evolving data privacy, security, and data protection laws and regulations and the costs to comply with such laws and regulations or any ineffective compliance efforts with such laws and regulations may adversely impact our business
6. 22Our use or our third-party service providers’ or business partners’ use of AI, automated decision-making and machine learning technologies and the evolving regulatory framework in this area may subject us to risks or heightened costs that could adversely affect business, results of operation and financial condition
7. 23If tax laws change or we experience adverse outcomes resulting from examination of our tax returns or disagreements with taxing authorities, it could adversely affect our business, financial condition, and results of operations
8. 24We may become subject to litigation brought by third parties claiming infringement, misappropriation, or other violation by us of their intellectual property rights
9. 25Climate change or legal, regulatory or market measures to address climate change may negatively affect our business, results of operations, and financial condition
10. 26The increasing focus on ESG and sustainability matters or the failure or perceived failure to meet our ESG and sustainability goals may increase our costs, harm our reputation or adversely affect our business
11. 27We are involved in legal proceedings and disputes, which could adversely impact our business, results of operations, and financial condition
12. 28Our failure to comply with laws and regulations relating to reimbursement of healthcare goods and services may subject us to penalties and adversely impact our reputation, business, results of operations, financial condition, and cash flows
13. 29Our insurance program may not cover claims brought against us, deny coverage of claims, or be inadequate to cover future losses
14. 30Any failure to obtain, maintain, protect and enforce our intellectual property rights, or the failure of the strength or scope of our intellectual property rights, could harm our business, financial condition, and results of operations

Risks Related to Financial and Economic Market Conditions

1. 31Foreign currency exchange rate fluctuations could have a significant impact on our results of operations
2. 32Our profitability and cash flows may be adversely affected by inflationary pressures
3. 33Uncertain global and domestic macro-economic and political conditions could materially adversely affect our business, results of operations, and financial condition
4. 34Our manufacturing business is exposed to price fluctuations of key commodities, which may negatively impact our results of operations and cash flows

Risks Related to Our Indebtedness

1. 35Our substantial indebtedness could adversely affect our financial condition, our ability to operate our business or react to changes in the economy or our industry, prevent us from fulfilling our obligations under our debts, and divert our cash flow from operations for debt payments
2. 36The credit agreement that governs the Senior Secured Credit Facilities and the indentures that govern the Senior Notes will each impose significant operating and financial restrictions on our subsidiaries, which may prevent us from capitalizing on business opportunities

Risks Related to Our Organizational Structure

1. 37Our tax receivable agreement confers benefits upon certain of our pre-IPO owners
2. 38In certain cases, payments under the tax receivable agreement may significantly exceed the actual benefits Medline Inc. realizes in respect of the tax attributes subject to the tax receivable agreement
3. 39The application of certain valuation assumptions under the tax receivable agreement in the case of certain changes of control or other events may impair our ability to consummate change of control transactions or negatively impact the value received by owners of our Class A common stock

Risks Related to Ownership of our Class A Common Stock

1. 40The Designating Stockholders hold a significant percentage of our stock, and their interests may conflict with ours or yours in the future
2. 41Our amended and restated certificate of incorporation does not limit the ability of our Sponsors, the Mills family, and certain other pre-IPO investors to compete with us, and they may have investments in businesses whose interests conflict with ours
3. 42We will incur increased costs and have become subject to additional regulations and requirements as a result of becoming a public company, which could lower our profits, make it more difficult to run our business, or divert management’s attention from our business
4. 43Failure to comply with requirements to design, implement, and maintain effective internal controls could have a material adverse effect on our business and stock price
5. 44If securities or industry analysts do not publish research or reports about our business, or if they downgrade their recommendations regarding our Class A common stock, our stock price and trading volume could decline
6. 45We cannot predict the impact our dual class structure may have on the market price of our Class A common stock
7. 46The market price of shares of our Class A common stock may be volatile or may decline regardless of our operating performance, which could cause the value of your investment to decline
8. 47You may be diluted by the future issuance of additional Class A common stock or Common Units in connection with our incentive plans, acquisitions or otherwise
9. 48We may issue preferred stock whose terms could materially adversely affect the voting power or value of our Class A common stock
10. 49If we or our pre-IPO owners sell additional shares of our Class A common stock or are perceived by the public markets as intending to sell them, the market price of our Class A common stock could decline
11. 50Anti-takeover provisions in our organizational documents and Delaware law might discourage or delay acquisition attempts for us that you might consider favorable